Dynavax Technologies Corporation (DVAX) Posts Q2 EPS Loss of $0.09, Revenue Tops Expectations
Tweet
Share
E-mailGet Alerts DVAX Hot Sheet
Price: $15.50 --0%
Financial Fact:
Research and development: 23.23M
Today's EPS Names:
PLCE, COE, JVA, More
Financial Fact:
Research and development: 23.23M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Dynavax Technologies Corporation (NASDAQ: DVAX) reported Q2 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $7.27 million versus the consensus estimate of $6.13 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q2 EPS by 1c
- RH (RH) Tops Q1 EPS by 12c
- J. M. Smucker (SJM) Tops Q4 EPS by 12c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
